Home › Funds › Nine Ten Capital Management LLC › IRMD
Nine Ten Capital Management LLC position in IRMD
IRADIMED CORP · Health Care
Nine Ten Capital Management LLC reported holding 96,330 shares of IRMD (IRADIMED CORP) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 16.91% of its reported portfolio and ranking #3 among its reported holdings. Nine Ten Capital Management LLC has disclosed IRMD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Nine Ten Capital Management LLC's IRMD position evolved
Nine Ten Capital Management LLC first disclosed a stake in IRMD in Q3 2023 at 771,311 shares (US$34.2M). The position peaked in Q3 2025 at 771,384 shares, worth US$54.9M. Across 13 filings, Nine Ten Capital Management LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 96,330 shares valued at US$8.3M — a reduction of -160,232 shares quarter over quarter.. Notable position changes include a 44% trim in Q4 2025 (shares fell 1% over the following quarter), a 62% trim in Q3 2026 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 771.31K | $34.22M | New |
| Q4 2023 | 799.37K | $37.95M | Add |
| Q1 2024 | 809.37K | $35.60M | Add |
| Q2 2024 | 877.80K | $38.57M | Add |
| Q3 2024 | 905.93K | $45.56M | Add |
| Q4 2024 | 905.93K | $49.83M | Hold |
| Q1 2025 | 872.00K | $45.76M | Reduce |
| Q2 2025 | 872.00K | $52.14M | Hold |
| Q3 2025 | 771.38K | $54.89M | Reduce |
| Q4 2025 | 428.48K | $41.68M | Reduce |
| Q1 2026 | 334.49K | $32.20M | Reduce |
| Q2 2026 | 256.56K | $24.52M | Reduce |
| Q3 2026 | 96.33K | $8.31M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRMD and 13F data
IRMD (IRADIMED CORP) is a Health Care company. 46 other funds we track also report a position in IRMD — the largest reported positions include Bridge City Capital, LLC (US$8.4M), SHAKER INVESTMENTS LLC/OH (US$7.9M), Uniplan Investment Counsel, Inc. (US$6.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRMD
- Bridge City Capital, LLC 96.97K sh · $8.36M · Q3 2026
- SHAKER INVESTMENTS LLC/OH 91.31K sh · $7.87M · Q3 2026
- Uniplan Investment Counsel, Inc. 75.72K sh · $6.53M · Q3 2026
- Davidson Capital Management Inc. 63.02K sh · $5.43M · Q3 2026
More on Nine Ten Capital Management LLC
FAQ
How long has Nine Ten Capital Management LLC held IRMD?
Nine Ten Capital Management LLC has disclosed IRMD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Nine Ten Capital Management LLC's current position in IRMD?
As of Q3 2026, Nine Ten Capital Management LLC holds 96.33K shares of IRMD (IRADIMED CORP), valued at $8.31M, representing 16.91% of its reported portfolio and ranking #3.
Has Nine Ten Capital Management LLC been buying or selling IRMD?
In the latest 13F filing (Q3 2026), Nine Ten Capital Management LLC reduced its position in IRMD. The position peaked in Q3 2025 at 771.38K shares.
Which other funds hold IRMD?
Other major institutional holders of IRMD include Bridge City Capital, LLC, SHAKER INVESTMENTS LLC/OH, Uniplan Investment Counsel, Inc., among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.